Evidence map›Paper›PMID 38168833›Full record

ArticleDiscover oncology2024

Suppression of the long non-coding RNA LINC01279 triggers autophagy and apoptosis in lung cancer by regulating FAK and SIN3A.

Jiancong Wu, Xiaobi Huang, Xiaofang Li, Honglian Zhou, Xiaorao Chen, Yongyang Chen, Yudong Guo, Jian Huang, Hanqing Huang, Zhong Huang and 4 more

Open access · goldAbstract read
In one paragraph

Article in Discover oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Jiancong Wu *Department of Pulmonary Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Xiaobi Huang *Department of Pulmonary Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Xiaofang LiCenter for Pathological Diagnosis and Research, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Honglian ZhouDepartment of Pulmonary Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Xiaorao ChenDepartment of Pulmonary Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Yongyang ChenDepartment of Pulmonary Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Yudong GuoDepartment of Pulmonary Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Jian HuangDepartment of Thoracic Surgery, Maoming People's Hospital, Maoming, China.
Hanqing HuangDepartment of Thoracic Surgery, Maoming People's Hospital, Maoming, China.
Zhong HuangDepartment of Pulmonary Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Guoan ChenSchool of Medicine, Southern University of Science and Technology, Shenzhen, China.
Zhixiong YangDepartment of Pulmonary Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China. yangzhixiong068@126.com.
Jian ZhangSchool of Medicine, Southern University of Science and Technology, Shenzhen, China. jianzhang008@hotmail.com.
Wenmei SuDepartment of Pulmonary Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China. suwenmei123@hotmail.com.
Guangdong Medical College · CNSouthern University of Science and Technology · CN

Funding

National Natural Science Foundation of China 81871883National Natural Science Foundation of China 8197276National Natural Science Foundation of China 82073388
6 · The paper itself

Abstract

Long non-coding RNAs play critical roles in the development of lung cancer by functioning as tumor suppressors or oncogenes. Changes in the expression of LINC01279 have been associated with cell differentiation and human diseases. However, the mechanism underlying LINC01279 activity in tumorigenesis is not clear. Here, we analyzed the function of LINC01279 in lung adenocarcinoma using clinical samples, xenografts, and non-small-cell lung cancer cell lines. We found that LINC01279 is highly expressed in lung adenocarcinoma and may be considered as a predictive factor for this cancer. Knockdown of LINC01279 prevents tumor growth in xenografts and in cancer cell lines by activating autophagy and apoptosis. Molecularly, we revealed that LINC01279 regulates the expression of focal adhesion kinase and extracellular-regulated kinase signaling. In addition, it complexes with and stabilizes the transcriptional co-repressor SIN3A protein. Suppression of focal adhesion kinase and SIN3A also induces apoptosis and prevents tumor progression, suggesting that they may at least in part mediate the oncogenic activity of LINC01279. These results identify LINC01279 as a possible oncogene that plays an important role in the development of lung cancer. Our findings provide insights into the mechanism underlying LINC01279-mediated oncogenesis of lung adenocarcinoma. They may help to discover potential therapeutic targets for cancer diagnosis and prognosis.

Indexed as

ApoptosisAutophagyFAKLINC01279lncRNALung adenocarcinomaSIN3A

Identifiers

PMID38168833
PMCPMC10761653
OpenAlexW4390495220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.